Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR Harmony: Long-term Safety of Bempedoic Acid in Hyperlipidemia
NCT02666664Phase 3Completed
- Sponsor
- Esperion Therapeutics
- Start
- Jan 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of bempedoic acid in hypercholesterolemia, atherosclerotic cardiovascular disease (ASCVD), sponsored by Esperion Therapeutics. Started Jan 2016; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemiaatherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT02666664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666664.